Considering their immune-cold nature, strategies to turn these tumors into immunologically hot cancers such as STING (Stimulator of Interferon Genes) agonists, oncolytic viruses, and cancer vaccines—seem to be good candidate for further studies. This evidence concerns the gene STING1 and cancer.